Crystal structure of methionine aminopeptidase from hyperthermophile, Pyrococcus furiosus. 1998

T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka, 565, Japan.

The structure of methionine aminopeptidase from hyperthermophile Pyrococcus furiosus (PfMAP) with an optimal growth temperature of 100 degreesC was determined by the multiple isomorphous replacement method and refined in three different crystal forms, one monoclinic and two hexagonal, at resolutions of 2.8, 2.9, and 3.5 A. The resolution of the monoclinic crystal form was extended to 1.75 A by water-mediated transformation to a low-humidity form, and the obtained diffraction data used for high-resolution structure refinement. This is the first description of a eukaryotic type methionine aminopeptidase structure. The PfMAP molecule is composed of two domains, a catalytic domain and an insertion domain, connected via two antiparallel beta-strands. The catalytic domain, which possesses an internal 2-fold symmetry and contains two cobalt ions in the active site, resembles the structure of a prokaryotic type MAP from Escherichia coli (EcMAP), while the structure of the insertion domain containing three helices has a novel fold and accounts for a major difference between the eukaryotic and prokaryotic types of methionine aminopeptidase. Analysis of the PfMAP structure in comparison with EcMAP and other mesophile proteins reveals several factors which may contribute to the hyperthermostability of PfMAP: (1) a significantly high number of hydrogen bonds and ion-pairs between side-chains of oppositely charged residues involved in the stabilization of helices; (2) an increased number of hydrogen bonds between the positively charged side-chain and neutral oxygen; (3) a larger number of buried water molecules involved in crosslinking the backbone atoms of sequentially separate segments; (4) stabilization of two antiparallel beta-strands connecting the two domains of the molecule by proline residues; (5) shortening of N and C-terminal tails and stabilization of the loop c3E by deletion of three residues.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D004795 Enzyme Stability The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. Enzyme Stabilities,Stabilities, Enzyme,Stability, Enzyme
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000626 Aminopeptidases A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11. Aminopeptidase

Related Publications

T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
April 1998, Biochemistry,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
March 2000, Biochemistry,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
February 2009, The FEBS journal,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
July 2004, European journal of biochemistry,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
December 2003, Acta crystallographica. Section D, Biological crystallography,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
July 2012, Proteins,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
May 1999, Protein science : a publication of the Protein Society,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
April 1992, Applied and environmental microbiology,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
June 2009, Archives of biochemistry and biophysics,
T H Tahirov, and H Oki, and T Tsukihara, and K Ogasahara, and K Yutani, and K Ogata, and Y Izu, and S Tsunasawa, and I Kato
November 1992, The Journal of biological chemistry,
Copied contents to your clipboard!